应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVIR Atea Pharmaceuticals, Inc.
休市中 12-20 15:59:59 EST
3.19
+0.06
+1.92%
盘后
3.19
+0.00
0.00%
16:13 EST
最高
3.32
最低
3.11
成交量
124.27万
今开
3.11
昨收
3.13
日振幅
6.55%
总市值
2.69亿
流通市值
2.06亿
总股本
8,446万
成交额
398.11万
换手率
1.92%
流通股本
6,467万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.11%
市场透视 · 12-21 00:50
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.11%
Atea Pharmaceuticals, Inc.盘中异动 股价大涨9.22%
市场透视 · 12-16
Atea Pharmaceuticals, Inc.盘中异动 股价大涨9.22%
Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.30%
市场透视 · 12-11
Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.30%
Atea Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.14%报2.96美元
市场透视 · 12-05
Atea Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.14%报2.96美元
嗡嗡声--美国股票走势-纳米核能、捷蓝航空、越野飞机
路透中文 · 12-05
嗡嗡声--美国股票走势-纳米核能、捷蓝航空、越野飞机
Atea Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.17%报3.30美元
市场透视 · 12-04
Atea Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.17%报3.30美元
嗡嗡声--美国股票走势-礼来、通用汽车、美元树
路透中文 · 12-04
嗡嗡声--美国股票走势-礼来、通用汽车、美元树
BUZZ-复合药物在中期研究中达到主要目标,Atea Pharma 公司业绩上升
路透中文 · 12-04
BUZZ-复合药物在中期研究中达到主要目标,Atea Pharma 公司业绩上升
Atea Pharmaceuticals, Inc.2024财年第三财季实现净利润-31.15百万美元,同比增加6.00%
市场透视 · 11-17
Atea Pharmaceuticals, Inc.2024财年第三财季实现净利润-31.15百万美元,同比增加6.00%
Atea Pharmaceuticals, Inc.盘中异动 急速拉升5.06%报3.53美元
市场透视 · 11-06
Atea Pharmaceuticals, Inc.盘中异动 急速拉升5.06%报3.53美元
Atea Pharmaceuticals, Inc.盘中异动 大幅跳水5.10%报3.63美元
市场透视 · 10-22
Atea Pharmaceuticals, Inc.盘中异动 大幅跳水5.10%报3.63美元
Atea Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%
市场透视 · 10-16
Atea Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%
Atea Pharmaceuticals, Inc.盘中异动 快速下跌5.04%
市场透视 · 09-24
Atea Pharmaceuticals, Inc.盘中异动 快速下跌5.04%
Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.10%报3.63美元
市场透视 · 09-21
Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.10%报3.63美元
BUZZ--美国股票走势-Atea Pharmaceuticals、Adobe、Similarweb
Reuters · 09-13
BUZZ--美国股票走势-Atea Pharmaceuticals、Adobe、Similarweb
BUZZ-Atea Pharma 因 COVID 药物在后期研究中失败而下跌
Reuters · 09-13
BUZZ-Atea Pharma 因 COVID 药物在后期研究中失败而下跌
Atea Pharmaceuticals, Inc.2024财年第二财季实现净利润-40.52百万美元,同比减少43.79%
自选股智能写手 · 08-17
Atea Pharmaceuticals, Inc.2024财年第二财季实现净利润-40.52百万美元,同比减少43.79%
Atea Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.00%报3.78美元
自选股智能写手 · 08-16
Atea Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.00%报3.78美元
Atea Pharmaceuticals, Inc.盘中异动 早盘大幅拉升9.25%
自选股智能写手 · 08-13
Atea Pharmaceuticals, Inc.盘中异动 早盘大幅拉升9.25%
Atea Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.05%报3.44美元
自选股智能写手 · 08-08
Atea Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.05%报3.44美元
加载更多
公司概况
公司名称:
Atea Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Atea Pharmaceuticals, Inc.于2012年7月注册成立,并于2014年3月开始主要运营。该公司是一家临床阶段的生物制药公司,致力于发现,开发和商业化抗病毒治疗剂,以改善遭受威胁生命的病毒感染的患者的生活。
发行价格:
--
{"stockData":{"symbol":"AVIR","market":"US","secType":"STK","nameCN":"Atea Pharmaceuticals, Inc.","latestPrice":3.19,"timestamp":1734728399999,"preClose":3.13,"halted":0,"volume":1242722,"hourTrading":{"tag":"盘后","latestPrice":3.19,"preClose":3.19,"latestTime":"16:13 EST","volume":39147,"amount":124878.37,"timestamp":1734729219035},"delay":0,"floatShares":64669065,"shares":84463059,"eps":-2.071312,"marketStatus":"休市中","marketStatusCode":7,"change":0.06,"latestTime":"12-20 15:59:59 EST","open":3.11,"high":3.315,"low":3.11,"amount":3981083.538718,"amplitude":0.065495,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.071312,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1604030400000,"adjPreClose":3.13,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.13,"preClose":3.13,"latestTime":"09:28 EST","volume":310,"amount":970.400037,"timestamp":1734704880092},"postHourTrading":{"tag":"盘后","latestPrice":3.19,"preClose":3.19,"latestTime":"16:13 EST","volume":39147,"amount":124878.37,"timestamp":1734729219035},"volumeRatio":1.4734232445963438,"impliedVol":2.6681,"impliedVolPercentile":0.9246},"requestUrl":"/m/hq/s/AVIR","defaultTab":"news","newsList":[{"id":"2493426281","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493426281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493426281?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:50","pubTimestamp":1734713422,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时50分,Atea Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.11%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.63%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005022984cfe97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005022984cfe97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2491692122","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨9.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692122?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359486,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分,Atea Pharmaceuticals, Inc.股票出现异动,股价急速上涨9.22%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223126a1f3428c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223126a1f3428c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2490042519","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490042519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490042519?lang=zh_cn&edition=full","pubTime":"2024-12-11 02:25","pubTimestamp":1733855133,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日02时25分,Atea Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.30%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.92%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211022533a1e3fb75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211022533a1e3fb75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2489468852","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.14%报2.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489468852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489468852?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:38","pubTimestamp":1733409511,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时38分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.14%。截至发稿,该股报2.96美元/股,成交量2.6289万股,换手率0.03%,振幅4.82%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223831a1d69d5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223831a1d69d5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2489055115","title":"嗡嗡声--美国股票走势-纳米核能、捷蓝航空、越野飞机","url":"https://stock-news.laohu8.com/highlight/detail?id=2489055115","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489055115?lang=zh_cn&edition=full","pubTime":"2024-12-05 00:05","pubTimestamp":1733328315,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30,道琼斯工业平均指数.DJI上涨0.31%,报44,846.04点;标准普尔500指数.SPX上涨0.29%,报6,067.26点;纳斯达克综合指数.IXIC上涨0.84%,报19,644.70点。标准普尔 500 指数.PG.INX百分比涨幅前三名是: ** Salesforce Inc CRM.N,上涨 8.8. ** Vistra Corp VST.N,上涨 5.7 标准普尔 500 指数.PL.INX跌幅前三名: ** Globe Life Inc GL.N,下跌 8.2. 由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3S3N5182:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","GM","LU2237443895.HKD","IE00BMPRXR70.SGD","MSM","LU0251131958.USD","LU2362541513.USD","HRTX","CYCN","CRGY","LEV","SRM","BK4561","LLY","BK4527","DLTR","RLMD","PSTG","CCRN","LU1951200564.SGD","RBOT","NVAX","SG9999014021.USD","BK4196","LU0056508442.USD","ORIS","LU0642271901.SGD","AES","GL","ADM","CBRL","VST","LU1323610961.USD","BK4155","NNE","MKTX","SG9999015978.USD","CURV","LU0792757196.USD","JBLU","BK4213","CRM","LU2290526834.HKD","AVIR","LU1571399168.USD"],"gpt_icon":1},{"id":"2488190863","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.17%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488190863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488190863?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:57","pubTimestamp":1733324277,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时57分,Atea Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.17%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225757971ba1f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225757971ba1f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2488919496","title":"嗡嗡声--美国股票走势-礼来、通用汽车、美元树","url":"https://stock-news.laohu8.com/highlight/detail?id=2488919496","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488919496?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:24","pubTimestamp":1733322276,"startTime":"0","endTime":"0","summary":".N ** Novavax Inc NVAX.O:BUZZ - 因向诺和诺德出售2亿美元捷克生产基地而上涨 nL3N3N50NS ** Heron Therapeutics Inc HRTX.O:BUZZ - 因法院对 Cinvanti 专利的有利裁决而上涨。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3S3N511Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4579","BK4504","LU0689472784.USD","BK4213","IE0009355771.USD","LU2322448957.HKD","MRVL","SG9999014898.SGD","BK4581","BK4550","RLMD","LU0122379950.USD","LU0070302665.USD","LU0187121727.USD","LU1046421795.USD","NVAX","BK4007","LU2237443382.USD","LU0385154629.USD","LU0320765489.SGD","SG9999015945.SGD","LU1868836914.USD","IE00B1BXHZ80.USD","LLY","LU0096364046.USD","LU2236285917.USD","AVIR","SGXZ81514606.USD","LU0130102774.USD","LU1803068979.SGD","SG9999018865.SGD","HRTX","LU0648001328.SGD","BK4559","LU0251142724.SGD","LU0251131958.USD","CRGY","IE00BQXX3F31.USD","LU0820561909.HKD","LU0345770308.USD","LU0477156797.USD","CRM","LU2023250504.SGD","DLTR","GM","LU0456855351.SGD","BK4516","LU2491050071.SGD","BK4538","LU1064131342.USD"],"gpt_icon":1},{"id":"2488319337","title":"BUZZ-复合药物在中期研究中达到主要目标,Atea Pharma 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2488319337","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488319337?lang=zh_cn&edition=full","pubTime":"2024-12-04 21:04","pubTimestamp":1733317441,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3S3N50X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2484548975","title":"Atea Pharmaceuticals, Inc.2024财年第三财季实现净利润-31.15百万美元,同比增加6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484548975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484548975?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773092,"startTime":"0","endTime":"0","summary":"11月17日,Atea Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第三财季净利润为-31.15百万美元,同比增加6.00%;其中营业收入为0.00美元,每股基本收益为-0.37美元。机构评级:截至2024年11月17日,当前有1家机构对Atea Pharmaceuticals, Inc.目标价做出预测,其中目标均价为6.20美元,其中最低目标价为6.20美元,最高目标价为6.20美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000621a23e0832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000621a23e0832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR"],"gpt_icon":0},{"id":"2481984476","title":"Atea Pharmaceuticals, Inc.盘中异动 急速拉升5.06%报3.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481984476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481984476?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:21","pubTimestamp":1730906482,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时21分,Atea Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.06%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623212298e40ed4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623212298e40ed4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2477189166","title":"Atea Pharmaceuticals, Inc.盘中异动 大幅跳水5.10%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477189166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477189166?lang=zh_cn&edition=full","pubTime":"2024-10-22 01:34","pubTimestamp":1729532048,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日01时34分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.10%。截至发稿,该股报3.63美元/股,成交量8.7629万股,换手率0.10%,振幅6.02%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.76%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022013408971a16c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022013408971a16c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2475171389","title":"Atea Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475171389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475171389?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:30","pubTimestamp":1729092655,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时30分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.01%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.53%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016233056971a0a9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016233056971a0a9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2469412748","title":"Atea Pharmaceuticals, Inc.盘中异动 快速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469412748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469412748?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:51","pubTimestamp":1727121113,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时51分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.04%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为2.65%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092403515398e387ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092403515398e387ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2469676252","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.10%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469676252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469676252?lang=zh_cn&edition=full","pubTime":"2024-09-21 00:38","pubTimestamp":1726850309,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日00时38分,Atea Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.10%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.64%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921003829ab64ea9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921003829ab64ea9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2467778520","title":"BUZZ--美国股票走势-Atea Pharmaceuticals、Adobe、Similarweb","url":"https://stock-news.laohu8.com/highlight/detail?id=2467778520","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467778520?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:21","pubTimestamp":1726233701,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 9月13日 - 华尔街周五有望小幅高开,因为投资者重新评估了美联储下周加大降息力度的可能性,而波音公司则在该公司工厂工人罢工后下跌。美东时间9:08,道指电子盘 上涨0.23%,报41,239点。标普500指数小型股 上涨0.22%,报收于5,614.5点;纳斯达克100指数小型股 下跌0.01%,报收于19,445.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0370786039.SGD","LU1023059493.AUD","LU0300736492.USD","HK0000320223.HKD","IE00B0JY6N72.USD","LU0070302665.USD","LU0516423091.SGD","IE00B3M56506.USD","LU0307460666.USD","PK","STLD","LU0157215616.USD","HK0000320264.USD","HST","RH","LU0175139822.USD","UPWK","L","LU0496367417.USD","NEM","LU0140636845.USD","HAL","LU0650527681.SGD","NBIX","NFE","NUE","LU0965508806.USD","LU1720051108.HKD","GEHC","LU0823416689.USD","LU0124676726.USD","WYNN","RLJ","SMWB","IE00B19Z3B42.SGD","CAL","LU0861579265.USD","APLE","LU0516422952.EUR","LU0170899867.USD","AVIR","ADBE","LU0472753341.HKD","IE0004445239.USD","DRH","LU2326559502.SGD","LU0588546209.SGD"],"gpt_icon":1},{"id":"2467296247","title":"BUZZ-Atea Pharma 因 COVID 药物在后期研究中失败而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2467296247","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467296247?lang=zh_cn&edition=full","pubTime":"2024-09-13 19:53","pubTimestamp":1726228417,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 9月13日 - ** 药物开发商Atea Pharmaceuticals 股价盘前下跌13.1%至3.19美元** 该公司称,其用于治疗Covid-19的试验性抗体药物bemnifosbuvir与安慰剂相比,未能显示 (link),需要住院治疗或死亡的患者人数在统计学上显著减少。** 该研究在2221名轻度至中度Covid-19高危患者中进行了药物测试** 截至上次收盘,该公司股价年累计上涨 20.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2460249740","title":"Atea Pharmaceuticals, Inc.2024财年第二财季实现净利润-40.52百万美元,同比减少43.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460249740","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460249740?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824013,"startTime":"0","endTime":"0","summary":"8月17日,Atea Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第二财季净利润为-40.52百万美元,同比减少43.79%;其中营业收入为0.00美元,每股基本收益为-0.48美元。机构评级:截至2024年8月17日,当前有2家机构对Atea Pharmaceuticals, Inc.目标价做出预测,其中目标均价为5.44美元,其中最低目标价为4.00美元,最高目标价为6.88美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000118959f28a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000118959f28a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR"],"gpt_icon":0},{"id":"2459403092","title":"Atea Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.00%报3.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459403092","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459403092?lang=zh_cn&edition=full","pubTime":"2024-08-16 01:27","pubTimestamp":1723742823,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日01时27分,Atea Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.00%。截至发稿,该股报3.78美元/股,成交量11.6651万股,换手率0.14%,振幅3.75%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.48%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816012703a1d47693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816012703a1d47693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2459012559","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘大幅拉升9.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459012559","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459012559?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:32","pubTimestamp":1723555931,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时32分,Atea Pharmaceuticals, Inc.股票出现异动,股价快速上涨9.25%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132119f278dc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132119f278dc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2458346791","title":"Atea Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.05%报3.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458346791","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458346791?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:58","pubTimestamp":1723132684,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时58分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.05%。截至发稿,该股报3.44美元/股,成交量9.5313万股,换手率0.11%,振幅5.66%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为2.51%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235804af96a22c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235804af96a22c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ateapharma.com","stockEarnings":[{"period":"1week","weight":0.0887},{"period":"1month","weight":0.0095},{"period":"3month","weight":-0.1308},{"period":"6month","weight":-0.0727},{"period":"1year","weight":0.0159},{"period":"ytd","weight":0.0459}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atea Pharmaceuticals, Inc.于2012年7月注册成立,并于2014年3月开始主要运营。该公司是一家临床阶段的生物制药公司,致力于发现,开发和商业化抗病毒治疗剂,以改善遭受威胁生命的病毒感染的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.218105},{"month":2,"riseRate":0.5,"avgChangeRate":-0.06977},{"month":3,"riseRate":0.25,"avgChangeRate":-0.039529},{"month":4,"riseRate":0,"avgChangeRate":-0.223714},{"month":5,"riseRate":0.5,"avgChangeRate":0.09522},{"month":6,"riseRate":0.25,"avgChangeRate":-0.051956},{"month":7,"riseRate":0.75,"avgChangeRate":0.097964},{"month":8,"riseRate":0.5,"avgChangeRate":0.022245},{"month":9,"riseRate":0.25,"avgChangeRate":-0.074667},{"month":10,"riseRate":0.5,"avgChangeRate":-0.140755},{"month":11,"riseRate":0.4,"avgChangeRate":-0.089908},{"month":12,"riseRate":0.8,"avgChangeRate":0.067474}],"exchange":"NASDAQ","name":"Atea Pharmaceuticals, Inc.","nameEN":"Atea Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atea Pharmaceuticals, Inc.,AVIR,Atea Pharmaceuticals, Inc.股票,Atea Pharmaceuticals, Inc.股票老虎,Atea Pharmaceuticals, Inc.股票老虎国际,Atea Pharmaceuticals, Inc.行情,Atea Pharmaceuticals, Inc.股票行情,Atea Pharmaceuticals, Inc.股价,Atea Pharmaceuticals, Inc.股市,Atea Pharmaceuticals, Inc.股票价格,Atea Pharmaceuticals, Inc.股票交易,Atea Pharmaceuticals, Inc.股票购买,Atea Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}